Evotec SE American Depositary Shares (EVO) Stock Price

EVOStock

$1.89−45.18%52W

Market Cap$671.69M

P/E—

PEG Ratio1.42

Div yield—

Beta2.05

EVO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-57.94%

Price vs S&P 500 (4W)-9.28%

PEG Ratio1.42

VGM Score40.86

P/CF (Annual)45.82x

Book Value / Share (Quarterly)$4.60

P/TBV (Annual)1.24x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)1.61%

Cash Flow / Share (Quarterly)$-0.35

Price vs S&P 500 (YTD)-50.88%

Gross Margin (TTM)11.47%

Net Profit Margin (TTM)-26.02%

EPS (TTM)$-1.27

10-Day Avg Trading Volume0.83M

EPS Excl Extra (TTM)$-1.27

Revenue Growth (5Y)9.49%

EPS (Annual)$-0.68

ROI (Annual)-8.21%

Gross Margin (Annual)14.49%

Net Profit Margin (5Y Avg)-7.40%

Cash / Share (Quarterly)$3.05

Revenue Growth QoQ (YoY)-21.67%

ROA (Last FY)-6.04%

Revenue Growth TTM (YoY)-5.48%

EBITD / Share (TTM)$-1.04

ROE (5Y Avg)-7.99%

Operating Margin (TTM)-21.15%

Cash Flow / Share (Annual)$-0.60

P/B Ratio0.98x

P/B Ratio (Quarterly)1.09x

Net Income / Employee (Annual)$-26,491

EV / Revenue (TTM)0.92x

Net Interest Coverage (TTM)-6.37x

ROA (TTM)-11.18%

EV / EBITDA (TTM)25.67x

EPS Incl Extra (Annual)$-0.68

Current Ratio (Annual)2.07x

Quick Ratio (Quarterly)1.50x

3-Month Avg Trading Volume0.81M

52-Week Price Return-45.18%

Revenue / Employee (TTM)$190,919

Tangible BV / Share (Quarterly)$2.59

P/S Ratio (Annual)0.87x

Asset Turnover (Annual)0.46x

52-Week High$8.52

Operating Margin (5Y Avg)-4.57%

EPS Excl Extra (Annual)$-0.68

CapEx CAGR (5Y)-3.57%

Tangible BV CAGR (5Y)4.54%

26-Week Price Return-46.69%

Quick Ratio (Annual)1.96x

13-Week Price Return-34.45%

Total Debt / Equity (Annual)0.55x

Current Ratio (Quarterly)1.68x

Enterprise Value$797.68M

Revenue / Share Growth (5Y)6.38%

Asset Turnover (TTM)0.43x

Book Value / Share Growth (5Y)0.71%

Revenue / Employee (Annual)$202,122

Inventory Turnover (Annual)22.31x

Pretax Margin (Annual)-11.01%

Cash / Share (Annual)$3.27

3-Month Return Std Dev60.88%

Gross Margin (5Y Avg)19.80%

Net Income / Employee (TTM)$-49,714

EBITDA Interim CAGR (5Y)20.02%

ROE (Last FY)-12.72%

Net Interest Coverage (Annual)-11.10x

EPS Basic Excl Extra (Annual)$-0.68

P/FCF (TTM)13.46x

Receivables Turnover (TTM)4.20x

Total Debt / Equity (Quarterly)0.55x

EPS Incl Extra (TTM)$-1.27

Receivables Turnover (Annual)4.83x

ROI (TTM)-15.70%

P/S Ratio (TTM)0.92x

Pretax Margin (5Y Avg)-5.56%

Revenue / Share (Annual)$5.18

Tangible BV / Share (Annual)$5.14

Price vs S&P 500 (52W)-63.49%

Year-to-Date Return-40.29%

5-Day Price Return-4.41%

EPS Normalized (Annual)$-0.68

ROA (5Y Avg)-3.63%

Net Profit Margin (Annual)-13.13%

Month-to-Date Return-4.57%

EBITD / Share (Annual)$-0.05

Operating Margin (Annual)-7.13%

LT Debt / Equity (Annual)0.24x

P/CF (TTM)36.55x

ROI (5Y Avg)-5.22%

LT Debt / Equity (Quarterly)0.43x

EPS Basic Excl Extra (TTM)$-1.27

P/TBV (Quarterly)1.94x

P/B Ratio (Annual)1.19x

Inventory Turnover (TTM)19.84x

Pretax Margin (TTM)-24.04%

Book Value / Share (Annual)$5.35

Price vs S&P 500 (13W)-37.24%

Beta2.05x

P/FCF (Annual)27.97x

Revenue / Share (TTM)$4.90

ROE (TTM)-24.55%

52-Week Low$3.71

vGradeB

gGradeD

mGradeD

vgmGradeC

EVO Earnings Surprise History

Q2 25-0.14est. -0.15

Q3 25-0.14est. -0.19

Q4 250.05est. 0.08

Q1 26-0.40est. -0.20

Q2 26-0.15est. -0.05

EVO Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.85

3.75

3.58

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
EVOEvotec SE American Depositary Shares	B	D	D	$1.89
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Evotec SE American Depositary Shares

Evotec is a drug discovery and contract development and manufacturing organization (CDMO) that partners with pharmaceutical, biotechnology, and academic organizations across multiple therapeutic areas including oncology, central nervous system disorders, and infectious diseases. The company operates through two main segments: Shared R&D services (approximately 80% of revenue), which provides drug discovery, development, and manufacturing on both fee-for-service and collaboration-based models, and Just-Evotec Biologics (approximately 20% of revenue), which offers CDMO services for biologics. With over 5,000 employees and 18 production sites across Europe and the United States, Evotec serves as an integrated partner throughout the drug development lifecycle.